Microglia are resident immune cells critically involved in the progression of many neurodegenerative diseases, including Alzheimer's disease (AD). We are developing small molecules and peptide-based probes to modulate microglial functions to better understand microglial biology and deliver therapeutic candidates targeting microglia for treating AD.